Related Experiment Video

Updated: May 24, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Stage B heart failure: rationale for screening

John J Atherton1

  • 1Department of Cardiology, Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Brisbane, Queensland, Australia. john_atherton@health.qld.gov.au

Heart Failure Clinics
|March 13, 2012
PubMed

Insights

Early detection and management of asymptomatic left ventricular systolic dysfunction (Stage B heart failure) are crucial for reducing the overall burden of heart failure. Screening these individuals can lead to improved patient outcomes.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Heart failure presents a significant health burden, often exacerbated by a lack of focus on presymptomatic stages.
  • Symptomatic heart failure cases continue to rise due to inadequate attention to individuals in earlier, presymptomatic phases.

Purpose of the Study:

  • To review the rationale for early detection and management of Stage B heart failure.
  • To highlight asymptomatic left ventricular systolic dysfunction as a key modifiable antecedent to symptomatic heart failure.

Main Methods:

  • Review of existing literature and treatment efficacy studies.
  • Analysis of the potential benefits of screening for asymptomatic left ventricular systolic dysfunction.

Main Results:

  • Early detection and management of Stage B heart failure are essential for mitigating the impact of heart failure.
  • Evidence suggests that effective interventions exist for individuals with asymptomatic left ventricular systolic dysfunction, improving outcomes.

Conclusions:

  • A combined strategy of prevention, early detection, and management is necessary to address the heart failure epidemic.
  • Screening for and managing asymptomatic left ventricular systolic dysfunction is a viable approach to reduce future symptomatic heart failure cases and improve patient prognosis.

More Related Videos

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models07:49

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models

Published on: July 21, 2023

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.